𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction

✍ Scribed by K.A. Papp; S. Tyring; M. Lahfa; J. Prinz; C.E.M. Griffiths; A.M. Nakanishi; R. Zitnik; P.C.M. Van De Kerkhof; the Etanercept Psoriasis Study Group


Book ID
108668255
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
256 KB
Volume
152
Category
Article
ISSN
0007-0963

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Efficacy and safety of golimumab in pati
✍ Robert D. Inman; John C. Davis Jr.; DΓ©sirΓ©e Van Der Heijde; Laura Diekman; Joach πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 2 views

## Abstract ## Objective To evaluate the efficacy and safety of golimumab in patients with ankylosing spondylitis (AS) in the GO‐RAISE study. ## Methods Patients with active AS, a Bath AS Disease Activity Index (BASDAI) score β‰₯4, and a back pain score of β‰₯4 were randomly assigned in a 1.8:1.8:1

Efficacy and safety of leflunomide in th
✍ J. Peter Kaltwasser; Peter Nash; Dafna Gladman; Cheryl F. Rosen; Frank Behrens; πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 157 KB πŸ‘ 2 views

## Abstract ## Objective Current treatment options for psoriatic arthritis (PsA) are limited. Leflunomide, an oral pyrimidine synthesis inhibitor, is highly effective in the treatment of rheumatoid arthritis, and small studies have suggested similar efficacy in PsA. We undertook this double‐blind,